Cell-free DNA fetal fraction and preterm birth

American Journal of Obstetrics and Gynecology

Volumn 215, Issue 2, 2016, Pages 231.e1-231.e7

  Dugoff, Lorraine ^a   Barberio, Andrea ^b   Whittaker, Paul G ^a   Schwartz, Nadav ^a   Sehdev, Harish ^a   Bastek, Jamie A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

cell free deoxyribonucleic acid; fetal fraction; preterm birth

Indexed keywords

CELL FREE DNA; DNA; UNCLASSIFIED DRUG;

ADULT; ANEUPLOIDY; ARTICLE; BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBRYONIC AND FETAL FUNCTIONS; FEMALE; FETAL FRACTION; FETUS; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MEDICAL RECORD REVIEW; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; SYNCYTIOTROPHOBLAST; PREGNANCY; PREMATURE BIRTH; PROCEDURES; RISK ASSESSMENT; RISK FACTOR;

ADULT; DNA; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREMATURE BIRTH; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84963516510     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.02.009     Document Type: Article

References (23)

1. 1 Wang, E., Batey, A., Struble, C., Musci, T., Song, K., Oliphant, A., Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat Diagn 33 (2013), 662–666.
2. 2 Bianchi, D.W., Circulating fetal DNA: its origin and diagnostic potential—a review. Placenta 25 (2004), S93–S101.
3. 3 Gupta, A.K., Holzgreve, W., Huppertz, B., Malek, A., Schneider, H., Hahn, S., Detection of fetal DNA and RNA in placenta-derived syncytiotrophoblast microparticles generated in vitro. Clin Chem 50 (2004), 2187–2190.
4. 4 Taglauer, E.S., Wilkins-Haug, L., Bianchi, D.W., Review: cell-free DNA in the maternal circulation as an indication of placental health and disease. Placenta 28 (2014), S64–S68.
5. 5 Farina, A., LeShane, E.S., Romero, R., et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 193 (2005), 421–425.
6. 6 Leung, T.N., Zhang, J., Lau, T.K., Hjelm, N.M., Lo, Y.M., Maternal plasma fetal DNA as a marker for preterm labour. Lancet 352 (1998), 1904–1905.
7. 7 Quezada, M.S., Francisco, C., Dumitrascu-Biris, D., Nicolaides, K.H., Poon, L.C., Fetal fraction of cell-free DNA in maternal plasma in the prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol 45 (2015), 101–105.
8. 8 Poon, L.C.Y., Musci, T., Song, K., Syngelaki, A., Nicolaides, K.H., Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks’ gestation: relation to fetal and maternal characteristics and pregnancy outcomes. Fetal Diagn Ther 33 (2013), 215–223.
9. 9 Jakobsen, T.R., Clausen, F.B., Rode, L., Dziegiel, M.H., Tabor, A., High levels of fetal DNA are associated with increased risk of spontaneous preterm delivery. Prenat Diagn 32 (2012), 840–845.
10. 10 Bauer, M., Hutterer, G., Eder, M., et al. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome. Prenat Diagn 26 (2006), 831–836.
11. 11 Illanes, S., Gomez, R., Fornes, R., et al. Free fetal DNA levels in patients at risk of preterm labour. Prenat Diagn 31 (2011), 1082–1085.
12. 12 Stein, W., Muller, S., Gutersohn, K., Emons, G., Legler, T., Cell-free fetal DNA and adverse outcome in low risk pregnancies. Eur J Obstet Gynecol Reprod Biol 166 (2013), 10–13.
13. 13 American College of Obstetricians and Gynecologists. Noninvasive prenatal testing for fetal aneuploidy. ACOG Committee opinion no. 545. Obstet Gynecol 120 (2012), 1532–1534.
14. 14 Nygren, A.O., Dean, J., Jensen, T.J., et al. Quantification of fetal DNA by use of methylation-based DNA discrimination. Clin Chem 56 (2010), 1627–1635.
15. 15 Kim, S.K., Hannum, G., Geis, J., et al. Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts. Prenat Diagn 35 (2015), 1–6.
16. 16 Dugoff, L., Hobbins, J.C., Malone, F.D., et al. First trimester maternal serum PAPP-A and free-beta sub-unit hCG concentrations and nuchal translucency are associated with obstetric complications: a population based screening study (The FASTER Trial). Am J Obstet Gynecol 191 (2004), 1446–1451.
17. 17 Dugoff, L., Hobbins, J.C., Malone, F.D., et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 106 (2005), 260–267.
18. 18 Kim, Y.M., Chaiworapongsa, T., Gomez, R., et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of the membranes. Am J Obstet Gynecol 187 (2002), 1137–1142.
19. 19 Misra, V.K., Hobel, C.J., Sing, C.F., Placental blood flow and the risk of preterm delivery. Placenta 30 (2009), 619–624.
20. 20 Khong, S.L., Kane, S.C., Brennecke, S.P., da Silva Costa, F., First-trimester uterine artery Doppler analysis in the prediction of later pregnancy complications. Dis Markers, 2015, 2015, 679730.
21. 21 Robertson, W.B., Brosens, I., Pijnenborg, R., De Wolf, F., The making of the placental bed. Eur J Obstet Gynecol Reprod Biol 18 (1984), 255–266.
22. 22 Scharfe-Nugent, A., Corr, S.C., Carpenter, S.B., et al. TLR9 provokes inflammation in response to fetal DNA: mechanism for fetal loss in preterm birth and preeclampsia. J Immunol 188 (2012), 5706–5712.
23. 23 Premature birth report card. 2015. Available at: www.marchofdimes.org/premature-birth-report-card-united-states.pdf. Accessed January 26, 2016.